Cite

    Wu, H. et al. (2022). Hepatic interferon regulatory factor 8 expression suppresses hepatocellular carcinoma progression and enhances the response to anti–programmed cell death protein‐1 therapy. Hepatology. 76 (6), pp. 1602-1616. [Online].